BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8697436)

  • 1. Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions.
    Ravi D; Nalinakumari KR; Rajaram RS; Nair MK; Pillai MR
    Cancer Lett; 1996 Aug; 105(2):139-46. PubMed ID: 8697436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of apoptosis-related protein in epithelial dysplasia and squamous cell carcinoma].
    Guan W; Yu S; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):65-8. PubMed ID: 11955367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis-associated proteins in oral lymphomas from HIV-positive patients.
    Regezi JA; McMillan A; Dekker N; Daniels TE; Silverman S; Schoelch M; Ziober BL
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Aug; 86(2):196-202. PubMed ID: 9720096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo programmed cell death in oral cancer.
    Ravi D; Ramadas K; Mathew BS; Nalinakumari KR; Nair MK; Pillai MR
    Histopathology; 1999 Mar; 34(3):241-9. PubMed ID: 10217565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis.
    Itakura M; Mori S; Park NH; Bonavida B
    Int J Oncol; 2000 Mar; 16(3):591-7. PubMed ID: 10675494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.
    Sinicrope FA; Ruan SB; Cleary KR; Stephens LC; Lee JJ; Levin B
    Cancer Res; 1995 Jan; 55(2):237-41. PubMed ID: 7812951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.
    Zhang GJ; Kimijima I; Abe R; Kanno M; Katagata N; Hara K; Watanabe T; Tsuchiya A
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2329-35. PubMed ID: 9815631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
    Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
    Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
    Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bcl-2, p53, Ki-67 and apoptotic index in cancerous and precancerous lesions of the oral mucosa].
    Tetè S; Pappalardo S; Fioroni M; Salini L; Imperatrice AM; Perfetti G
    Minerva Stomatol; 1999 Sep; 48(9):419-25. PubMed ID: 10638175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
    Kaur J; Srivastava A; Ralhan R
    Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation and apoptosis within the oral mucosa "hemangiomas".
    Dyduch G; Okoń K
    Pol J Pathol; 2000; 51(2):93-6. PubMed ID: 10974933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
    Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
    Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
    Mallick S; Patil R; Gyanchandani R; Pawar S; Palve V; Kannan S; Pathak KA; Choudhary M; Teni TR
    J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the tumour suppressor gene p53 in oral cancer.
    Langdon JD; Partridge M
    Br J Oral Maxillofac Surg; 1992 Aug; 30(4):214-20. PubMed ID: 1380822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of antigen retrieval for immunohistochemical detection of p53 over-expression in malignant and benign oral mucosa: a cautionary note.
    Dowell SP; Ogden GR
    J Oral Pathol Med; 1996 Feb; 25(2):60-4. PubMed ID: 8667257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
    Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo expression of p53 and Bcl-2 and their role in programmed cell death in premalignant and malignant lung lesions.
    Koty PP; Zhang H; Franklin WA; Yousem SA; Landreneau R; Levitt ML
    Lung Cancer; 2002 Feb; 35(2):155-63. PubMed ID: 11804688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. bcl-2 expression in the spectrum of preinvasive breast lesions.
    Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
    Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.